Supply Chain Disruption and Rising Costs – How Africa's Medical Importers Are Responding in 2026

The first half of 2026 has brought mounting pressure on Africa's medical supply chains, with the Africa Centres for Disease Control and Prevention issuing a stark warning about the risk of dangerous shortages of essential medical supplies across the continent.

The Scale of the Problem

More than half of African countries were facing shortages of essential health products, including vaccines and tuberculosis medicines, according to WHO's Africa office in late 2025. The situation has been compounded by shipping cost increases, with new war taxes and fuel surcharges pushing container costs to as high as US$4,000.

The Middle East conflict has further exacerbated the situation, as the Middle East serves as the primary gateway for supplying the African continent. Sudan has reportedly seen critical medicines stranded in Dubai ports. Africa imports more than 70% of its medicines, primarily from India and China, and disruptions to shipping routes have extended transit times and increased transport costs.

Structural Weaknesses Exposed

Beyond external shocks, the crisis has laid bare structural weaknesses in African medical procurement. Delayed public purchasing, opaque distribution networks, and poor supply-chain visibility often turn external shocks into full-blown supply crises. West Africa's US$11 billion health market remains under pressure, with between 85 and 99% of medical equipment and in vitro diagnostics imported, resulting in supply delays, high costs, and severe operational disruptions in hospitals.

Foreign exchange shortages, weak cold-chain infrastructure, and rising out-of-pocket healthcare spending further worsen the situation.

The Localisation Response

In response, localisation efforts are gaining momentum. The African Export-Import Bank has established a US$75 million support facility for the production of medical devices, vaccines, and biologics. Nigeria has set a target to increase local medicine production from 30% in 2024 to 70% by 2030. The African Continental Free Trade Area is expected to accelerate the development of regional distribution hubs in Nigeria, Ghana, and Côte d'Ivoire.

The Presidential Declaration on Advancing Local Manufacturing of Health Products, adopted in February 2026, reaffirms the ambition for Africa to meet at least 60% of its health product needs through local manufacturing by 2040.

Strategic Implications for Suppliers

For medical equipment and consumables suppliers, the current environment underscores the value of reliable, established supply chain partners. Hospitals and laboratories facing shortages are seeking suppliers who can offer consistent lead times, competitive pricing despite currency volatility, and local stock availability. A one-stop foreign trade service provider with deep African market experience can help manufacturers navigate these challenges – from maintaining regional inventory buffers to managing customs and logistics under volatile conditions.